[1] DE HAAS M,THURIK F F,KOELEWIJN J M,et al.Haemolytic disease of the fetus and newborn[J]. Vox Sang,2015,109(2):99-113. [2] Bhutani VK, JohnsonL, SivieriEM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbiliru-binemia in healthy term and near-term newborns[J]. Pediatrics, 1999,103:6-14. [3] 中华医学会儿科学分会新生儿学组.新生儿黄疸诊疗原则的专家共识[J].中华儿科杂志,2010,48(9):685-686. [4] JOHNSON L,BHUTANI V K,KARP K,et al.Clinical report from the pilot USA Kernicterus Registry (1992 to 2004)[J]. J Perinatol,2009,29(Suppl 1):S25-S45. [5] 中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会.新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志,2014,52(10):745-748. [6] 封志纯,刘敬.母源性新生儿疾病[M].2019:98-104. [7] PAYAM KHAJA PASHA R,SHOKRI F. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN)[J]. Iran J Immunol,2008,5(4):189-200. [8] 黄强,郭华,杨光.不同剂量丙种球蛋白联合光疗治疗ABO溶血患儿的疗效观察[J].临床血液学杂志,2021,34(4):275-277. [9] BHUTANI V K,JOHNSON L,SIVIERI E M.Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns[J]. Pediatrics,1999,103(1):6-14. [10] 杨成民,刘进,赵桐茂.中华输血学[M].2017:624-626. [11] 俞君,高建娣,陈正,等.154例新生儿重度高胆红素血症换血治疗的临床特点及预后分析[J].中华急诊医学杂志,2019,28(9):1141-1145. [12] 刘倩,王笑欢,郭凯,等. 新生儿换血前后实验室指标的变化趋势[J].临床输血与检验,2021,23(2):177-180. [13] 林园. 新生儿溶血病(HDN)免疫血液学试验推荐方案[J].中国输血杂志,2012,25(2):95-100. [14] 王丽,朱阳泉,徐长根,等. 母婴血型不合致新生儿溶血病231例分析[J].临床输血与检验,2010,12(4):335-337. [15] 王志. 孕妇血型不规则抗体检测对预防新生儿溶血病的作用研究[J].临床检验杂志(电子版),2018,7(4):755. [16] 中国输血协会免疫血液学专业委员会.胎儿新生儿溶血病实验室检测专家共识[J].临床输血与检验,2021,23(1):20-23. [17] 莫秋红,袁茜茜,周先果,等.Rh血型不合致新生儿溶血病的实验结果分析及换血治疗[J].国际检验医学杂志,2012,33(13):1655-1657. |